allergies

Editor's note: Story updated with additional information about generic pricing on August 17.

The Food and Drug Administration has approved the first identical alternative to the EpiPen, which is widely used to save children and adults suffering from dangerous allergic reactions.

The FDA Thursday authorized Teva Pharmaceuticals USA to sell generic versions of the EpiPen and EpiPen Jr for adults and children who weigh more than 33 pounds.

It's already been one of the worst flu seasons in recent memory. Now, you can add a late-blooming, but hard-hitting, allergy season to the list of reasons for some Florida residents' sinus miseries.

For most people, buying a "fragrance-free" or "hypoallergenic" moisturizer that turns out to be neither might be frustrating, but not harmful. But for people with sensitive skin or conditions like eczema or psoriasis, it can be a big problem.

"I will start to itch and I have to get it off my body right away," says 62-year-old Kathryn Walter, who lives in Ann Arbor, Mich.

Walter has a severe case of eczema and chooses moisturizers that claim to be free of fragrance and allergy-causing additives. But more often than not, Walter ends up with a product that clearly isn't.

If you have ever noticed an itchy or tingly sensation in your mouth after biting into a raw apple, carrot, banana or any of the fruits and veggies listed here, read on.

People who are allergic to pollen are accustomed to runny eyes and sniffles this time of year. But some seasonal allergy sufferers have it worse: They can develop allergic reactions to common fruits and vegetables.

Recall Of Some EpiPens Extends To U.S.

Apr 3, 2017

The pharmaceutical company Mylan NV announced a recall of some brand-name EpiPen and EpiPen Jr. auto-injectors on Friday.

The EpiPen, the anti-allergy device that has been under investigation because of huge price increases, is soon going to have some competition.

Kaleo Pharmaceuticals, a small privately held drugmaker, says it plans to bring the Auvi-Q epinephrine auto-injector back onto the market in 2017.

Both the Auvi-Q and EpiPen devices inject a dose of epinephrine into the thigh of a person experiencing a severe allergic reaction.

The drug company that makes the EpiPen says it isn't nearly as profitable as many people assume it is.

At least that's the message Mylan NV CEO Heather Bresch will try to deliver to members of Congress today.

Bresch, who is scheduled to testify before the House Oversight and Government Reform Committee, is expected to tell lawmakers that the company earns $100 profit on each two-pack of EpiPen auto-injectors, even though they carry a $600 price tag.